Search results

707 results

Sorted by Relevance . Sort by Date

In development Remove In development filter
Proposed Remove Proposed filter
Technology appraisal guidance Remove Technology appraisal guidance filter
Clinical guidelines Remove Clinical guidelines filter
Medical technologies guidance Remove Medical technologies guidance filter
Safe staffing guidelines Remove Safe staffing guidelines filter
Quality standards Remove Quality standards filter

Sleepio for adults with difficulty sleeping (MT443)

In development [GID-MT552] Expected publication date: 03 August 2021

Type

Medical technologies guidance

Status

In development
Endo-SPONGE for treating low rectal anastomotic leakage (MT461)

In development [GID-MT539] Expected publication date: TBC

Type

Medical technologies guidance

Status

In development
Peezy Midstream for urine collection (MT446)

In development [GID-MT538] Expected publication date: TBC

Type

Medical technologies guidance

Status

In development
The MAGEC system for spinal lengthening in children with scoliosis

In development [GID-MT544] Expected publication date: 15 September 2020

Type

Medical technologies guidance

Status

In development
Prontosan for acute and chronic wounds

In development [GID-MT551] Expected publication date: 05 October 2021

Type

Medical technologies guidance

Status

In development
DHT pilot: myCOPD for self-management of chronic obstructive pulmonary disease (COPD)

In development [GID-MT531] Expected publication date: TBC

Type

Medical technologies guidance

Status

In development
GID-MT550 DyeVert for reducing contrast media in coronary and peripheral angiography (MT488)

In development [GID-MT550] Expected publication date: 04 October 2021

Type

Medical technologies guidance

Status

In development
SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)

In development [GID-MT526] Expected publication date: TBC

Type

Medical technologies guidance

Status

In development
GID-MT554 KardiaMobile for the ambulatory detection of atrial fibrillation

In development [GID-MT554] Expected publication date: 06 January 2022

Type

Medical technologies guidance

Status

In development
GID-MT557 Novii Wireless Patch System for maternal and fetal monitoring (MT509)

In development [GID-MT557] Expected publication date: 22 March 2022

Type

Medical technologies guidance

Status

In development
MT507 Plus Sutures for preventing surgical site infection

In development [GID-MT558] Expected publication date: 09 November 2021

Type

Medical technologies guidance

Status

In development
GID-MT561 ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections

In development [GID-MT561] Expected publication date: 02 February 2022

Type

Medical technologies guidance

Status

In development
Synergo for non-muscle-invasive bladder cancer

In development [GID-MT553] Expected publication date: 30 November 2021

Type

Medical technologies guidance

Status

In development
Alpha Stim AID (MT477)

In development [GID-MT542] Expected publication date: 08 March 2021

Type

Medical technologies guidance

Status

In development
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MT241)

In development [GID-MT548] Expected publication date: 04 May 2021

Type

Medical technologies guidance

Status

In development
3C Patch System for treating diabetic foot ulcers (MT539)

In development [GID-MT559] Expected publication date: 19 January 2022

Type

Medical technologies guidance

Status

In development
MT476 UroShield for preventing catheter-associated urinary tract infections

In development [GID-MT560] Expected publication date: 15 March 2022

Type

Medical technologies guidance

Status

In development
MT582 AnaConDa-S for sedation with volatile anaesthetics in intensive care

In development [GID-MT556] Expected publication date: 23 February 2022

Type

Medical technologies guidance

Status

In development
Danis Stent for acute oesophageal variceal bleeds (MT450)

In development [GID-MT537] Expected publication date: 08 April 2021

Type

Medical technologies guidance

Status

In development
GID-MT562 FibroScan for assessing liver fibrosis and cirrhosis in primary care

In development [GID-MT562] Expected publication date: TBC

Type

Medical technologies guidance

Status

In development
GID-MT563 NPi-200 for pupillary light reflex in critical care patients

In development [GID-MT563] Expected publication date: TBC

Type

Medical technologies guidance

Status

In development
Multiple myeloma - lenalidomide (maintenance, post autologous stem cell transplantation) [ID475]

In development [GID-TAG430] Expected publication date: 03 March 2021

Type

Technology appraisal guidance

Status

In development
Baricitinib for treating moderate to severe atopic dermatitis [ID1622]

In development [GID-TA10562] Expected publication date: 03 March 2021

Type

Technology appraisal guidance

Status

In development
Eryaspase with chemotherapy for previously treated advanced or metastatic pancreatic cancer [ID3781]

Proposed [GID-TA10637] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Naxitamab with GM-CSF for treating relapsed or refractory high-risk neuroblastoma [ID3769]

Proposed [GID-TA10638] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Remdesivir for treating COVID-19 [ID3808]

Proposed [GID-TA10721] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Pembrolizumab with docetaxel for treating hormone-relapsed metastatic prostate cancer untreated with chemotherapy [ID3801]

Proposed [GID-TA10668] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
STG320 for treating persistent allergic rhinitis caused by house dust mites (ID1278)

Proposed [GID-TA10279] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Tocilizumab for treating systemic sclerosis (ID1396)

Proposed [GID-TA10346] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Intravenous zanamivir for treating influenza in hospital [ID1196]

Proposed [GID-TA10298] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged under 18 with non-malignant diseases [ID3745]

Proposed [GID-TA10599] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Cabotegravir with rilpivirine for the oral treatment of HIV-1 [ID3731]

Proposed [GID-TA10604] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Bupivacaine–meloxicam for treating postoperative pain [ID2728]

Proposed [GID-TA10716] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Mepolizumab for treating hypereosinophilic syndrome [ID3749]

Proposed [GID-TA10755] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Aducanumab for treating mild cognitive impairment in early Alzheimer's disease [ID3763]

Proposed [GID-TA10739] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Secukinumab for treating enthesitis-related arthritis or juvenile psoriatic arthritis [ID3738]

Proposed [GID-TA10598] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Vosoritide for treating achondroplasia in children and young people under 18 years [ID3807]

Proposed [GID-TA10700] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Netarsudil-latanoprost for previously treated open-angle glaucoma or ocular hypertension [ID1363]

Proposed [GID-TA10741] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs [ID2690]

Proposed [GID-TA10666] Expected publication date: 26 August 2021

Type

Technology appraisal guidance

Status

Proposed
Eflornithine with sulindac for treating familial adenomatous polyposis [ID1543]

Proposed [GID-TA10536] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment [ID3869]

Proposed [GID-TA10757] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Lurbinectedin with doxorubicin for treating advanced small-cell lung cancer after platinum-based chemotherapy [ID3872]

Proposed [GID-TA10758] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Sotagliflozin for treating type 2 diabetes [ID1657]

Proposed [GID-TA10665] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Ibrutinib with corticosteroids for untreated chronic graft versus host disease [ID3792]

Proposed [GID-TA10722] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitors [ID3813]

Proposed [GID-TA10691] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Selinexor for treating unresectable dedifferentiated advanced liposarcoma [ID3825]

Proposed [GID-TA10694] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Retifanlimab for treating advanced anal canal squamous cell carcinoma after platinum-based chemotherapy [ID3815]

Proposed [GID-TA10698] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Etranacogene dezaparvovec for treating haemophilia B [ID3812]

Proposed [GID-TA10699] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Tralokinumab for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3823]

Proposed [GID-TA10702] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Eptinezumab for preventing migraine [ID3803]

Proposed [GID-TA10677] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed